Contact

All Stories

  1. The Role of Microbial Exopolysaccharides in Preventing and Treating Cardiovascular Diseases

    Article • Microorganisms, June 2025, MDPI AG

    Dr Gabriel Lopez-Velazquez

  2. Swine Gut Lactic Acid Bacteria and Their Exopolysaccharides Differentially Modulate Toll-like Receptor Signaling Depending on the Agave Fructans Used as a Carbon Source

    Article • Animals, April 2025, MDPI AG

    Dr Gabriel Lopez-Velazquez

  3. The Arg108Cys Variant of Methylmalonyl-CoA Mutase: Clinical Implications for the Mexican Population Based on Molecular Dynamics and Docking

    Article • International Journal of Molecular Sciences, March 2025, MDPI AG

    Dr Gabriel Lopez-Velazquez

  4. In Vitro Evaluation of Esters of Quinoxaline-1,4-di-N-oxide Derivatives as New Antitaeniasis Agents and Their Inhibitory Activity Against Triosephosphate Isomerase

    Article • Pharmaceuticals, March 2025, MDPI AG

    Dr Gabriel Lopez-Velazquez

  5. Revisión comprensiva del uso eficaz de fructooligosacáridos en el proceso salud-enfermedad en niños

    Article • Acta Pediátrica de México, February 2025, Acta Pediatrica de Mexico

    Dr Gabriel Lopez-Velazquez

  6. Methylglyoxal-Induced Modifications in Human Triosephosphate Isomerase: Structural and Functional Repercussions of Specific Mutations

    Article • Molecules, October 2024, MDPI AG

    Dr Gabriel Lopez-Velazquez

  7. Selective Inhibition of Deamidated Triosephosphate Isomerase by Disulfiram, Curcumin, and Sodium Dichloroacetate: Synergistic Therapeutic Strategies for T-Cell Acute Lymphoblastic Leukemia in Jurkat Cells

    Article • Biomolecules, October 2024, MDPI AG

    Dr Gabriel Lopez-Velazquez

  8. TATA-Binding Protein-Based Virtual Screening of FDA Drugs Identified New Anti-Giardiasis Agents

    Article • International Journal of Molecular Sciences, June 2024, MDPI AG

    Dr Gabriel Lopez-Velazquez

  9. Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial

    Article • Frontiers in Gastroenterology, January 2024, Frontiers

    Dr Gabriel Lopez-Velazquez

  10. Crystal type, chain length and polydispersity impact the resistant starch type 3 immunomodulatory capacity via Toll-like receptors

    Article • Carbohydrate Polymers, January 2024, Elsevier

    Dr Gabriel Lopez-Velazquez

  11. β(2 → 1)-β(2 → 6) and β(2 → 1) fructans protect from impairment of intestinal tight junction's gene expression and attenuate human dendritic cell responses in a fructan-dependent fashion

    Article • Carbohydrate Polymers, November 2023, Elsevier

    Dr Gabriel Lopez-Velazquez

  12. Human Triosephosphate Isomerase Is a Potential Target in Cancer Due to Commonly Occurring Post-Translational Modifications

    Article • Molecules, August 2023, MDPI AG

    Dr Gabriel Lopez-Velazquez

  13. Safer new drugs for trypanosomiasis

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, July 2023, Taylor & Francis

    Dr Gabriel Lopez-Velazquez

  14. TLR 2/1 interaction of pectin depends on its chemical structure and conformation

    Article • Carbohydrate Polymers, March 2023, Elsevier

    Dr Gabriel Lopez-Velazquez

  15. β(2 → 1)-β(2 → 6) branched graminan-type fructans and β(2 → 1) linear fructans impact mucus-related and endoplasmic reticulum stress-related genes in goblet cells and attenuate inflammatory responses in a fructan dependent fashion

    Article • Food & Function, January 2023, Royal Society of Chemistry

    Dr Gabriel Lopez-Velazquez

  16. The Giardial Arginine Deiminase Participates in Giardia-Host Immunomodulation in a Structure-Dependent Fashion via Toll-like Receptors

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Dr Gabriel Lopez-Velazquez

  17. β(2→6)-Type fructans attenuate proinflammatory responses in a structure dependent fashion via Toll-like receptors

    Article • Carbohydrate Polymers, February 2022, Elsevier

    Dr Gabriel Lopez-Velazquez

  18. Improved yield, stability, and cleavage reaction of a novel tobacco etch virus protease mutant

    Article • Applied Microbiology and Biotechnology, January 2022, Springer Science + Business Media

    Dr Gabriel Lopez-Velazquez, Dr. C. Enrique Guerrero-Beltrán

  19. Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial

    Article • Gut Microbes, January 2022, Taylor & Francis

    Dr Gabriel Lopez-Velazquez

  20. Deamidated TPI is an efficacious target for cell-selective therapy in triple-negative breast cancer

    Article • November 2021, Cold Spring Harbor Laboratory Press

    Dr Gabriel Lopez-Velazquez

  21. Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase

    Article • International Journal of Molecular Sciences, August 2021, MDPI AG

    Dr Gabriel Lopez-Velazquez

  22. Limosilactobacillus reuteriATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial

    Article • Beneficial Microbes, April 2021, Wageningen Academic Publishers

    Dr Gabriel Lopez-Velazquez

  23. Delivery mode-associated gut microbiota in the first 3 months of life in a country with high obesity rates

    Article • Medicine, October 2020, Wolters Kluwer Health

    Dr Gabriel Lopez-Velazquez

  24. Rabeprazole inhibits several functions of Entamoeba histolytica related with its virulence

    Article • Parasitology Research, September 2020, Springer Science + Business Media

    Dr Gabriel Lopez-Velazquez

  25. Deamidated Human Triosephosphate Isomerase is a Promising Druggable Target

    Article • Biomolecules, July 2020, MDPI AG

    Dr Gabriel Lopez-Velazquez

  26. On the molecular and cellular effects of omeprazole to further support its effectiveness as an antigiardial drug

    Article • Scientific Reports, June 2019, Springer Science + Business Media

    Dr Gabriel Lopez-Velazquez

  27. Mechanisms of natural resistance of Balb/c mice to experimental liver amoebiasis

    Article • Bioscience Reports, May 2019, Portland Press Ltd.

    Dr Gabriel Lopez-Velazquez

  28. We found unusual proteolitic activities using lysates of Giardia trophozoites

    Article • Molecular and Biochemical Parasitology, March 2019, Elsevier

    Dr Gabriel Lopez-Velazquez

  29. Complement is a rat natural resistance factor to amoebic liver infection

    Article • Bioscience Reports, October 2018, Portland Press Ltd.

    Dr Gabriel Lopez-Velazquez

  30. First characterization of a microsporidial triosephosphate isomerase and the biochemical mechanisms of its inactivation to propose a new druggable target

    Article • Scientific Reports, June 2018, Springer Science + Business Media

    Dr Gabriel Lopez-Velazquez

  31. Efficacy of Lactobacillus reuteri DSM 17938 for infantile colic

    Article • Medicine, December 2017, Wolters Kluwer Health

    Dr Gabriel Lopez-Velazquez

  32. Morphological Studies of Nucleologenesis inGiardia lamblia

    Article • The Anatomical Record, February 2016, Wiley

    Dr Gabriel Lopez-Velazquez

  33. Proton pump inhibitors drastically modify triosephosphate isomerase from Giardia lamblia at functional and structural levels, providing molecular leads in the design of new antigiardiasic drugs

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, January 2016, Elsevier

    Dr Gabriel Lopez-Velazquez

  34. Effects of Fructans from Mexican Agave in Newborns Fed with Infant Formula: A Randomized Controlled Trial

    Article • Nutrients, October 2015, MDPI AG

    Dr Gabriel Lopez-Velazquez

  35. Structural Effects of Protein Aging: Terminal Marking by Deamidation in Human Triosephosphate Isomerase

    Article • PLOS One, April 2015, PLOS

    Dr Gabriel Lopez-Velazquez

  36. The Oxidative Fermentation of Ethanol in Gluconacetobacter diazotrophicus Is a Two-Step Pathway Catalyzed by a Single Enzyme: Alcohol-Aldehyde Dehydrogenase (ADHa)

    Article • International Journal of Molecular Sciences, January 2015, MDPI AG

    Dr Gabriel Lopez-Velazquez

  37. The Stability of G6PD Is Affected by Mutations with Different Clinical Phenotypes

    Article • International Journal of Molecular Sciences, November 2014, MDPI AG

    Dr Gabriel Lopez-Velazquez

  38. Omeprazole as an antigiardial drug

    Article • Antimicrobial Agents and Chemotherapy, September 2014, ASM Journals

    Dr Gabriel Lopez-Velazquez

  39. Diarrhea in Preschool Children and Lactobacillus reuteri: A Randomized Controlled Trial

    Article • PEDIATRICS, March 2014, American Academy of Pediatrics (AAP)

    Dr Gabriel Lopez-Velazquez

  40. The E104D mutation increases the susceptibility of human triosephosphate isomerase to proteolysis. Asymmetric cleavage of the two monomers of the homodimeric enzyme

    Article • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, December 2013, Elsevier

    Dr Gabriel Lopez-Velazquez

  41. Cloning, Expression, Purification and Characterization of His-Tagged Human Glucose-6-Phosphate Dehydrogenase: A Simplified Method for Protein Yield

    Article • The Protein Journal, October 2013, Springer Science + Business Media

    Dr Gabriel Lopez-Velazquez

  42. Structural and Functional Perturbation of Giardia lamblia Triosephosphate Isomerase by Modification of a Non-Catalytic, Non-Conserved Region

    Article • PLOS One, July 2013, PLOS

    Dr Gabriel Lopez-Velazquez

  43. Determining the molecular mechanism of inactivation by chemical modification of triosephosphate isomerase from the human parasite Giardia lamblia : A study for antiparasitic drug design

    Article • Proteins Structure Function and Bioinformatics, July 2011, Wiley

    Dr Gabriel Lopez-Velazquez

  44. Unraveling the mechanisms of tryptophan fluorescence quenching in the triosephosphate isomerase from Giardia lamblia

    Article • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, November 2008, Elsevier

    Dr Gabriel Lopez-Velazquez

  45. Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library

    Article • Parasitology, September 2008, Cambridge University Press

    Dr Gabriel Lopez-Velazquez

  46. Identification of nucleoli in the early branching protist Giardia duodenalis

    Article • International Journal for Parasitology, September 2008, Elsevier

    Dr Gabriel Lopez-Velazquez

  47. Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer

    Article • Molecular and Biochemical Parasitology, February 2008, Elsevier

    Dr Gabriel Lopez-Velazquez

  48. Crystal structure of a double mutant (C202A/A198V) of Triosephosphate isomerase from giardia lamblia

    Article • January 2007, Protein Data Bank, Rutgers University

    Dr Gabriel Lopez-Velazquez

  49. Disulfide Bridges in the Mesophilic Triosephosphate Isomerase from Giardia lamblia Are Related to Oligomerization and Activity

    Article • Journal of Molecular Biology, January 2007, Elsevier

    Dr Gabriel Lopez-Velazquez

  50. Nucleolar Ultrastructure in Trypanosoma cruzi

    Article • Microscopy and Microanalysis, July 2005, Cambridge University Press

    Dr Gabriel Lopez-Velazquez

  51. An unusual triosephosphate isomerase from the early divergent eukaryote Giardia lamblia

    Article • Proteins Structure Function and Bioinformatics, April 2004, Wiley

    Dr Gabriel Lopez-Velazquez

  52. Susceptibility to proteolysis of triosephosphate isomerase from two pathogenic parasites: Characterization of an enzyme with an intact and a nicked monomer

    Article • Proteins Structure Function and Bioinformatics, June 2002, Wiley

    Dr Gabriel Lopez-Velazquez

  53. Factors That Control the Reactivity of the Interface Cysteine of Triosephosphate Isomerase fromTrypanosoma bruceiandTrypanosoma cruzi†

    Article • Biochemistry, March 2001, American Chemical Society (ACS)

    Dr Gabriel Lopez-Velazquez

  54. Three-dimensional analysis of the arrangement of compact chromatin in the nucleus of G0 rat lymphocytes

    Article • Histochemistry and Cell Biology, February 1996, Springer Science + Business Media

    Dr Gabriel Lopez-Velazquez